Cell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other Diseases
SAN FRANCISCO, March 15, 2017 (GLOBE NEWSWIRE) -- Cell Design Labs, Inc. today announced the issuance of U.S. Patent No. 9,587,020, entitled, “Chimeric Antigen Receptor and Methods of Use Thereof.” This patent, issued to UC San Francisco (UCSF) and …